Effect of nimodipine on outcome in patients with traumatic subarachnoid haemorrhage: a systematic review

  title={Effect of nimodipine on outcome in patients with traumatic subarachnoid haemorrhage: a systematic review},
  author={Mervyn D.I. Vergouwen and Marinus Vermeulen and Yvo B Roos},
  journal={The Lancet Neurology},

Tables from this paper

Efficacy of nimodipine in the treatment of subarachnoid hemorrhage: a meta-analysis.

Nimodipine is effective in the treatment of SAH, lowering incidence of adverse reactions and therefore improving the prognosis of patients, according to a meta-analysis performed with Stata16.0 software.

Traumatic Subarachnoid Hemorrhage: A Scoping Review

Patients with tSAH associated with mTBI have a very low risk of clinical deterioration and surgical intervention and should be managed conservatively when considering ICU admission and the Helsinki and Stockholm CT scoring systems may be valuable tools to use when predicting outcome and mortality.

Effect of Progesterone Administration in Traumatic Subarachnoid Hemorrhage

This study demonstrated that progesterone did not result in different effects in patients with or without tSAH than those without based on initial brain imaging, and supports previous research findings; t SAH is correlated with more severe injury and worsened outcomes.

Ef fi cacy of nimodipine in the treatment of subarachnoid hemorrhage: a meta-analysis E fi cácia da nimodipina no tratamento da hemorragia subaracnoidea: uma metanálise

A meta-analysis of 10 randomized controlled trials evaluating the clinical effect of nimodipine adjuvant therapy by intravenous pump in the treatment of subarachnoid hemorrhage found that the treatment group had higher effective rate and lower incidence of adverse reactions.

Subarachnoid haemorrhage secondary to traumatic intracranial aneurysm of the posterior cerebral circulation: case series and literature review

SAH from ruptured posterior circulation TICA is associated with significant morbidity and mortality, and a high index of suspicion as well as prompt diagnosis, repeat imaging in selected cases, and treatment of any associated TICA can be crucial to a favourable outcome.

Comprehensive Assessment of Isolated Traumatic Subarachnoid Hemorrhage

Most tSAH patients without additional systemic injury were discharged home (68%), including 53% of patients with a GCS score of 3–8, however, older patients were more likely to be discharged to a rehabilitation facility (p<0.0...

Nimodipine and Its Use in Cerebrovascular Disease: Evidence from Recent Preclinical and Controlled Clinical Studies

In the area of vascular cognitive impairment, short-term benefits of nimodipine do not justify its use as a long-term anti-dementia drug, and benefits obtained in elderly patients affected by subcortical vascular dementia require to be confirmed by other groups and in larger scale trials.

Nimodipine Reappraised: An Old Drug with a Future

This review seeks to establish a firm understanding of current data on nimodipine’s role in the mechanisms of delayed injury in aSAH, TBI, and ischemic stroke, and assess the extensive clinical data evaluating its use in these conditions.



Nimodipine in traumatic subarachnoid haemorrhage: A re-analysis of the HIT I and HIT II trials

A re-analysis of the HIT I data is provided to see whether it provides confirmatory evidence of the subgroup effect observed in HIT II, which suggests that the overall benefit of treating unselected head injured patients with nimodipine is unlikely to be clinically relevant.

Evaluation of nimodipine in the treatment of severe diffuse head injury: a double-blind placebo-controlled trial.

Oral nimodipine given for three weeks does not improve outcome in patients with severe diffuse head injury, and there was no significant difference in the functional and psychological outcome between the two groups.

Traumatic subarachnoid hemorrhage and its treatment with nimodipine. German tSAH Study Group.

Patients treated with nimodipine had a significantly less unfavorable outcome (death, vegetative survival, or severe disability) at 6 months than placebo-treated patients (25% vs. 46%, p = 0.02); the relative reduction in unfavorable outcome in the nimmodipine-treated group was even higher when only patients who complied with the protocol were considered.

Calcium Antagonists in Aneurysmal Subarachnoid Hemorrhage

Calcium antagonists reduce the risk of poor outcome and secondary ischaemia after aneurysmal SAH; the results for 'poor outcome' depend largely on a single large trial with oral nimodipine; the evidence for nicardipine, AT877 and magnesium is inconclusive.

A trial of the effect of nimodipine on outcome after head injury

It is unlikely that nimodipine has a marked effect on outcome (ie an increase in favourable outcome of >15%) after head injury of this severity but the study does not exclude a modest but clinically useful benefit.

A multicenter trial of the efficacy of nimodipine on outcome after severe head injury. The European Study Group on Nimodipine in Severe Head Injury.

A trend toward a favorable effect was seen in patients who exhibited traumatic subarachnoid hemorrhage on the computerized tomography (CT) scan obtained prior to entry into the study, consistent with the effect of nimodipine on secondary ischemia following spontaneous SAH.

Calcium channel blockers for acute traumatic brain injury.

The effect of nimodipine in a subgroup of brain injury patients with subarachnoid haemorrhage shows a beneficial effect, though the increase in adverse reactions suffered by the intervention group may mean that the drug is harmful for some patients.

Treatment of the traumatic cerebral vasospasm with the calciumchannel blocker nimodipine: a preliminary report.

Based on preliminary results, calciumchannel blocker reverses traumatic vasospasm and ameliorates physiologic function of the brain structures after severe head injury.

Nimodipine Increases Fibrinolytic Activity in Patients With Aneurysmal Subarachnoid Hemorrhage

The mechanism of increased fibrinolytic activity in patients with aneurysmal SAH is a decrease in the level of PAI-1, which is most likely caused by treatment with nimodipine.

Transcranial Doppler monitoring in head injury: relations between type of injury, flow velocities, vasoreactivity, and outcome.

Hyperperfusion, as based on ICA flow velocities, and vasospasm were correlated with diminished vasoreactivity, however, disturbed vasoreactivities, particularly during the first days, were common and did not necessarily predict an unfavorable outcome.